C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
12/2001
12/20/2001	WO2001096307A2 Cycloalkyl alkanoic acids as integrin receptor antagonists
12/20/2001	WO2001096305A1 Serine protease inhibitors
12/20/2001	WO2001096298A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
12/20/2001	WO2001096289A1 Sulfonamide derivatives
12/20/2001	WO2001096283A2 Hiv integrase inhibitors
12/20/2001	WO2001096266A1 Processes for fluorinating aromatic ring compounds
12/20/2001	WO2001095856A2 Urea derivative useful as an anti-cancer agent and process for preparing same
12/20/2001	WO2001074788A8 2-hydroxy-mutilin carbamate derivatives for antibacterial use
12/20/2001	WO2001051456A3 Antibacterial agents
12/20/2001	WO2001019770A3 Rxr modulators with improved pharmacologic profile
12/20/2001	WO2000072834A9 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
12/20/2001	US20010053855 Modified alkoxycarbonyloxypyridine as oligonucleotide blocking agent
12/20/2001	US20010053853 Alkanoic acid derivative; integrin receptor antagonist
12/20/2001	US20010053850 Novel synthesis of heteroarylamine intermediate compounds
12/20/2001	US20010052500 Adding a chelating agent continuously to a semiconductor manufacturing process waste stream containing a metal residue to form a metal complex with at least a portion of the metal residue, and removing the metal complex
12/20/2001	DE10104847A1 Water-soluble concentrates of alpha-tocopherol or its derivatives and polysorbate used in skin cosmetics, medicines, drinks or food supplements
12/20/2001	CA2412857A1 Hiv integrase inhibitors
12/20/2001	CA2411811A1 Sulfonamide derivatives
12/20/2001	CA2411805A1 Serine protease inhibitors
12/20/2001	CA2411495A1 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
12/19/2001	EP1164418A2 Color photothermographic elements comprising blocked developing agents
12/19/2001	EP1164138A1 Terpyridine-platinum (II) complexes
12/19/2001	EP1164131A1 Process for producing organic compounds by catalysis of imide compounds
12/19/2001	EP1163247A1 Pharmaceutical compositions comprising metal complexes
12/19/2001	EP1163238A1 Chemokine recpetor binding heterocyclic compounds
12/19/2001	EP1163237A1 Amide derivatives
12/19/2001	EP1163224A1 N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance
12/19/2001	EP1163223A1 Synthesis of 3-amino-3-aryl propanoates
12/19/2001	EP1163222A1 Process of preparing 3s-3-amino-3-aryl propionic acid and derivatives thereof
12/19/2001	EP1163215A1 Amino-thio-acrylonitriles as mek inhibitors
12/19/2001	EP1163213A1 Hydroxamic and carboxylic acid derivatives
12/19/2001	EP1163212A1 Amide derivatives
12/19/2001	EP1163208A2 Caspase inhibitors and uses thereof
12/19/2001	EP1162980A2 Use of pyridoxine compounds for the treatment of cardiovascular and related pathologies
12/19/2001	EP1162967A1 The use of certain affinity nmda antagonists as antidepressants
12/19/2001	EP1102592A4 Coumarin and related aromatic-based polymeric prodrugs
12/19/2001	EP1094816A4 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/19/2001	EP0847391B1 Aromatic compounds and pharmaceutical compositions containing them
12/19/2001	EP0813520B1 Arylsulfonylamino hydroxamic acid derivatives
12/19/2001	CN1327445A Transition metal compounds, catalyst for the production of alpha-olefins and process therefor
12/19/2001	CN1327443A Substituted anilides
12/19/2001	CN1327383A Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/19/2001	CN1326936A Ion liquid
12/19/2001	CN1076346C Process for producing aromatic or heteroaromatic sulfur compounds
12/19/2001	CN1076345C 2,3-diaminopropionic acid derivatives
12/18/2001	US6331640 Diaminopropionic acid derivatives
12/18/2001	US6331564 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease
12/18/2001	US6331563 N-Hydroxy-2-(Alkyl, Aryl, or Heteroaryl, Sulfanyl, Sulfinyl or Sulfonyl)-3-Substituted Alkyl, Aryl or Heteroarylamides as Matrix Metalloproteinase inhibitors
12/18/2001	US6331554 Antipicornaviral compounds, compositions containing them, and methods for their use
12/18/2001	US6331553 Inhibitors of nitric oxide synthase; treating cerebrovascular diseases
12/18/2001	US6331543 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use
12/18/2001	US6331542 Protease inhibitors
12/18/2001	CA2213815C Pyrrolidinyl hydroxamic acid compounds and their production process
12/13/2001	WO2001094339A1 Substituted pyridine herbicides
12/13/2001	WO2001094338A1 Admantane derivatives
12/13/2001	WO2001094314A1 Hydroxypyridone methide azo dyes
12/13/2001	WO2001094301A2 Factor viia inhibitory (thio)urea derivatives, their preparation and their use
12/13/2001	WO2001093885A1 Therapeutic agents - ii
12/13/2001	WO2001093884A1 Therapeutic agents - i
12/13/2001	WO2001093883A1 Therapeutic agents - iii
12/13/2001	WO2001068599A3 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form
12/13/2001	WO2001044194A3 Propanoic acid derivatives as integrin inhibitors
12/13/2001	WO2001042787A3 Immunoassay for neonicotinyl insecticides
12/13/2001	WO2001036660A3 Transition metal complexes attached to a polymer via a flexible chain
12/13/2001	US20010051732 3-urea compound from the 3-amido compound without azidation process which has risk of explosion; reaction with hypochlorite, hypobromite or lead tetraacetate and then an amine; ACAT inhibitor
12/13/2001	US20010051731 Para-amine substituted phenylamide glucokinase activators
12/13/2001	US20010051726 Method for producing 2-sulfonylpyridine derivatives and method for producing 2- { [ (2-pyridyl) methyl] thio} -1H-benzimidazole derivatives
12/13/2001	US20010051630 Use of hydroxylamine derivatives, and method and preparations for increasing the tolerance of field crops against weather stresses
12/13/2001	US20010051614 Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
12/13/2001	DE10111874A1 Verbessertes Verfahren zur Herstellung von substituierten Pyridinen An improved process for preparing substituted pyridines
12/13/2001	DE10028686A1 New hydroxypyridone methide azo dyes, useful in e.g. dyeing and printing hydrophobic fibers, ink-jet printing and color filters
12/13/2001	DE10027611A1 New 2,4-disubstituted 5-sulfonyl-benzamides or analogs having LDL receptor inducing activity, useful for treating or preventing hyperlipidemia or arteriosclerosis
12/13/2001	DE10023744A1 Elektrochrome Anzeigevorrichtung mit hoher Kantenschärfe Electrochromic display device with high edge sharpness
12/13/2001	CA2411596A1 Therapeutic agents - ii
12/13/2001	CA2345195A1 Color photothermographic elements comprising blocked developing agents
12/12/2001	EP1162197A1 Process for the preparation of pyridines by oxidation of dihydropyridines using methyl nitrite
12/12/2001	EP1162194A1 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use
12/12/2001	EP1161555A1 4-(4-hydroxystyryl)pyridine-containing substrates for an analyte dependent enzyme activation system
12/12/2001	EP1161422A1 Amine derivatives as protease inhibitors
12/12/2001	EP1161421A1 Inhibitors of protein tyrosine phosphatase
12/12/2001	EP1161416A1 Alpha-aminoacetic acid derivatives useful as alpha 4 beta 7 - receptor antagonists
12/12/2001	EP1161415A2 N-cyanomethylamides as protease inhibitors
12/12/2001	EP1161233A2 Lxr modulators
12/12/2001	EP1161232A1 Hydroxy diphenyl urea sulfonamides as il-8 receptor antagonists
12/12/2001	EP0938471B1 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
12/12/2001	EP0912499B1 Pesticides
12/12/2001	EP0810201B1 Preventive/remedy for liver disease
12/12/2001	EP0748319B1 Process for making an epoxide
12/12/2001	EP0716602B1 The primary and secondary neuroprotective effect of flupirtine in neurodegenerative diseases
12/12/2001	EP0675924B1 Cyclic-substituted unsymmetrical cyanine dyes
12/12/2001	CN1326444A Synthesis of intermediates useful in preparing tricyclic compounds
12/12/2001	CN1326442A Pesticides
12/12/2001	CN1326351A Use of certain drugs for treating nerve root injury
12/12/2001	CN1326114A Image element containing closed compounds for taking pictures
12/12/2001	CN1076034C Mixtures monoazopyridone dyes
12/11/2001	US6329550 For therapy of emphysema, osteoporosis, rheumatoid arthritis and neoplastic diseases
12/11/2001	US6329523 Compounds having a plurality of nitrogenous substitutents
12/11/2001	US6329405 As ileal bile acid transporter inhibitor, for therapy of hyperlipemia
12/11/2001	US6329402 Heterocycle-containing carboxylic acid derivative and drug containing the same
12/11/2001	US6329400 Formamide compounds as therapeutic agents

1 ... 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 ... 633